Lifestance Health Group Inc vs Orsted A/S
A head-to-head of Lifestance Health Group Inc (LFST) and Orsted A/S (DOGEF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | LFST | DOGEF |
|---|---|---|
| Market Cap | $2.99B | $537.44B |
| P/E (TTM) | 131.14 | 126.35 |
| Forward P/E | 72.46 | 0.66 |
| P/S | 2.00 | 7.34 |
| P/B | 2.06 | 2.00 |
| EV/EBITDA | 38.66 | 15.58 |
| Dividend Yield | — | — |
| Profit Margin | 1.55% | 2.97% |
| Gross Margin | 28.53% | -2.70% |
| Operating Margin | 1.80% | -2.70% |
| Revenue Growth (YoY) | +21.17% | +12.75% |
| FCF Yield | 5.99% | -5.87% |
| Debt / Equity | 21.21 | 83.48 |
| Current Ratio | 1.48 | 1.94 |
Which is better: Lifestance Health Group Inc or Orsted A/S?
- ✓Larger by market cap: Orsted A/S
- ✓Cheaper valuation (lower P/E): Orsted A/S
- ✓More profitable (net margin): Orsted A/S
- ✓Faster revenue growth: Lifestance Health Group Inc
- ✓Higher free-cash-flow yield: Lifestance Health Group Inc
Very close — each leads on 6 metrics.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Lifestance Health Group Inc with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.